These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18565004)

  • 21. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.
    Moryl N; Santiago-Palma J; Kornick C; Derby S; Fischberg D; Payne R; Manfredi PL
    Pain; 2002 Apr; 96(3):325-328. PubMed ID: 11973005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review.
    Mercadante S; Caraceni A
    Palliat Med; 2011 Jul; 25(5):504-15. PubMed ID: 21708857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods of Rotation From Another Strong Opioid to Methadone for the Management of Cancer Pain: A Systematic Review of the Available Evidence.
    McLean S; Twomey F
    J Pain Symptom Manage; 2015 Aug; 50(2):248-59.e1. PubMed ID: 25896106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid switching to improve pain relief and drug tolerability.
    Quigley C
    Cochrane Database Syst Rev; 2004; (3):CD004847. PubMed ID: 15266542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
    Mercadante S; Cascio AL; Casuccio A
    J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone Switching for Cancer Pain: A New Classification of Initiation Protocols, Based on a Critical Literature Review.
    Treillet E; Giet O; Picard S; Laurent S; Seresse L
    J Palliat Med; 2021 Dec; 24(12):1884-1894. PubMed ID: 34851186
    [No Abstract]   [Full Text] [Related]  

  • 30. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
    Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
    J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis.
    Dervan LA; Yaghmai B; Watson RS; Wolf FM
    Paediatr Anaesth; 2017 Mar; 27(3):228-239. PubMed ID: 28109052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the use of methadone for the treatment of chronic noncancer pain.
    Lynch ME
    Pain Res Manag; 2005; 10(3):133-44. PubMed ID: 16175249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone analgesia for children with advanced cancer.
    Davies D; DeVlaming D; Haines C
    Pediatr Blood Cancer; 2008 Sep; 51(3):393-7. PubMed ID: 18428431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotating to oral methadone in advanced cancer patients: a case series.
    Kilonzo I; Twomey F
    J Palliat Med; 2013 Sep; 16(9):1154-7. PubMed ID: 23631611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of age on opioid switching to methadone: a systematic review.
    Mercadante S; Bruera E
    J Palliat Med; 2012 Mar; 15(3):347-51. PubMed ID: 22352334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
    Hay JL; White JM; Bochner F; Somogyi AA; Semple TJ; Rounsefell B
    J Pain; 2009 Mar; 10(3):316-22. PubMed ID: 19101210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.